The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 975.00
Bid: 970.00
Ask: 975.00
Change: 20.00 (2.09%)
Spread: 5.00 (0.515%)
Open: 947.00
High: 982.00
Low: 946.00
Prev. Close: 955.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options & PDMR Dealing

26 Nov 2021 08:16

RNS Number : 7234T
CVS Group plc
26 November 2021
 

 

 

26 November 2021

CVS Group plc

("CVS", the "Company" and, together with its subsidiaries, the "Group")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing 

CVS Group plc (the "Company") announces that as part of its 2021/2022 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman 310 SAYE scheme options

Robin Alfonso 291 SAYE scheme options

Ben Jacklin 310 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,974 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2021, being the invitation date.

 

In response to accepted invitations, a total of 215,022 SAYE Scheme options over Ordinary Shares were granted on 25 November 2021, equating to 0.30% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2025.

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 

 

 

CVS Group plc

via MHP Communications

Richard Fairman, CEO

 

Jenny Farrer, Company Secretary

 

 

 

Singer Capital Markets (Nominated Adviser & Broker)

+44 20 7496 3000

Aubrey Powell / Jen Boorer / Rachel Hayes

 

 

 

MHP Communications (Financial PR)

+44 20 3128 8549

Andrew Jaques / Rachel Mann / Charles Hirst

 

   

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p

310

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p

291

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p

310

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIBDBDBDDGBL
Date   Source Headline
2nd Jul 20195:32 pmRNSHolding(s) in Company
1st Jul 20195:55 pmRNSExercise of Options and Total Voting Rights
28th Jun 20197:00 amRNSTrading Update
24th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20194:29 pmRNSHolding(s) in Company
3rd Jun 20193:32 pmRNSHolding(s) in Company
31st May 20193:11 pmRNSExercise of Options and Total Voting Rights
31st May 20193:07 pmRNSHolding(s) in Company
24th May 20195:02 pmRNSHolding(s) in Company
22nd May 20199:49 amRNSHolding(s) in Company
21st May 20199:15 amRNSHolding(s) in Company
20th May 201911:17 amRNSHolding(s) in Company
15th May 20194:09 pmRNSHolding(s) in Company
15th May 20194:09 pmRNSHolding(s) in Company
14th May 201911:28 amRNSHolding(s) in Company
9th May 201910:29 amRNSHolding(s) in Company
7th May 20192:30 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
18th Apr 20194:25 pmRNSHolding(s) in Company
18th Apr 201910:50 amRNSHolding(s) in Company
18th Apr 201910:26 amRNSHolding(s) in Company
16th Apr 20196:05 pmRNSHolding(s) in Company
10th Apr 20195:17 pmRNSHolding(s) in Company
2nd Apr 20199:42 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSInterim Results
26th Mar 20194:14 pmRNSHolding(s) in Company
25th Mar 20196:21 pmRNSHolding(s) in Company
25th Mar 20191:30 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
15th Feb 20194:46 pmRNSHolding(s) in Company
15th Feb 20194:45 pmRNSHolding(s) in Company
15th Feb 20194:44 pmRNSHolding(s) in Company
5th Feb 20194:20 pmRNSHolding(s) in Company
5th Feb 20194:20 pmRNSHolding(s) in Company
5th Feb 20194:00 pmRNSHolding(s) in Company
4th Feb 20194:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSTotal Voting Rights
31st Jan 20194:41 pmRNSDirector/PDMR and PCA Shareholding
31st Jan 20198:30 amRNSDirector/PDMR Shareholding
29th Jan 20197:00 amRNSTrading Update
10th Jan 20191:51 pmRNSHolding(s) in Company
19th Dec 20187:00 amRNSBlock Admission
18th Dec 20184:45 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSExercise of Options and Total Voting Rights
6th Dec 201811:41 amRNSDirector/PDMR and PCA Shareholding
4th Dec 20186:15 pmRNSDirector/PDMR and PCA Shareholding
4th Dec 20189:47 amRNSHolding(s) in Company
3rd Dec 20184:41 pmRNSHolding(s) in Company
3rd Dec 201810:30 amRNSGrant of Options under SAYE Option Scheme and TVR
3rd Dec 201810:06 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.